Executive Director of Arizona State University’s Biodesign Institute, United States
Joshua LaBaer is the executive director of Arizona State University’s Biodesign Institute. Dr. LaBaer is one of the nation’s foremost investigators in the rapidly expanding field of personalized diagnostics. Formerly founder and director of the Harvard Institute of Proteomics, LaBaer was recruited to ASU’s Biodesign Institute as the first Piper Chair in Personalized Medicine in 2009. LaBaer earned his medical degree and a doctorate in biochemistry and biophysics, from the University of California, San Francisco. He completed his medical residency at the Brigham and Women’s Hospital and a clinical fellowship in oncology at the Dana-Farber Cancer Institute, both in Boston. He has contributed more than 150 original research publications, reviews and chapters. LaBaer is an associate editor of the Journal of Proteome Research, a member of the National Cancer Institute’s Board of Scientific Advisors, Chair of the Early Detection Research Network Steering Committee and president of the U.S. Human Proteome Organization.
